FORCE improves the lives of the millions of individuals and families facing hereditary breast, ovarian, pancreatic, prostate, colorectal and endometrial cancers. Our community includes people with a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those diagnosed with Lynch syndrome. We accomplish this through our education, support, advocacy and research efforts.
We are dedicated to providing up-to-date, expert-reviewed information and resources that help people make informed medical decisions. Our strong, supportive community of peers and professionals ensures no one must face hereditary cancer alone. FORCE serves as a champion, unifying the community and advocating for awareness, access to care, and better treatment and prevention options.
Connect with us:
Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer
Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs
Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer
Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients